Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ASCB A SPAC II Acquisition (ASCB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisHeadlinesOwnershipShort InterestTrends About A SPAC II Acquisition Stock (NASDAQ:ASCB) 30 days 90 days 365 days Advanced Chart Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Get A SPAC II Acquisition alerts:Sign Up Key Stats Today's Range N/A50-Day Range$10.96▼$11.4752-Week Range N/AVolume2,300 shsAverage Volume13,818 shsMarket Capitalization$81.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewA SPAC II Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue prospective targets that are in the industries that apply technologies, such as Proptech and Fintech primarily in North America, Europe, and Asia. The company was incorporated in 2021 and is based in Singapore. A SPAC II Acquisition Corp. is a subsidiary of A SPAC II (Holdings) Corp.Read More… Receive ASCB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for A SPAC II Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address ASCB Stock News HeadlinesAngel Studios to Become a Publicly Traded Company via Business Combination with Southport Acquisition CorporationSeptember 12, 2024 | markets.businessinsider.comSemnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 bln dealSeptember 3, 2024 | reuters.comWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.December 22, 2024 | Behind the Markets (Ad)Semnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 billion dealSeptember 3, 2024 | msn.comBlack Spade Acquisition II Co Announces Closing Of $150 Million Initial Public OfferingAugust 29, 2024 | businesswire.comMelco chairman Lawrence Ho-backed SPAC raises US$150 million on NasdaqAugust 28, 2024 | msn.comThe SPAC Boom Was a Mess -- But Investors Can Learn These Valuable Lessons From ItAugust 28, 2024 | msn.comEvents.com to go public on NYSE through combination with SPACAugust 27, 2024 | msn.comSee More Headlines ASCB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of A SPAC II Acquisition own? Based on aggregate information from My MarketBeat watchlists, some other companies that A SPAC II Acquisition investors own include Andretti Acquisition Corp. II (POLEU), Agriculture & Natural Solutions Acquisition (ANSC), Alpha Star Acquisition (ALSA), Alchemy Investments Acquisition Corp 1 (ALCY), AI Transportation Acquisition (AITR), Aimfinity Investment Corp. I (AIMAU) and Aimei Health Technology (AFJK). Company Calendar Today12/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry N/A Sub-IndustryTrading Current SymbolNASDAQ:ASCB CUSIPN/A CIK1876716 WebN/A Phone65-6818-5796FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares7,296,000Free Float5,851,000Market Cap$81.64 million OptionableNot Optionable Beta-0.02 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:ASCB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding A SPAC II Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share A SPAC II Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASCB Stock Alerts